Company ProfilePremium

Misonix, Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Misonix, Inc. - Healthcare showcase

Year Founded & Workforce

1959

254 Employees

Industry

Healthcare

Services

Tumor Ablation
M

Misonix, Inc. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Misonix, Inc. Overview

Company Headquarters: New York, US

Founded: 1959

Workforce: ~254

Company Working: Misonix, Inc. specializes in the development and commercialization of ultrasonic surgical devices for spinal, neurosurgical, advanced wound care, and general surgery procedures. The company's products enhance clinical outcomes and benefit the entire healthcare system. In addition, the company derives revenue from a number of locations, including the US, the UK, the European Economic Area, Asia and the Asia Pacific, and South America. The company operates in more than 45 countries and is a recognized leader in advanced surgical tools offering unprecedented safety, speed, and precision.

Strategy

Their Misonix, Inc. goal is to provide highly innovative and quality products on a timely basis to their customers. It intends to offers best in class surgical ultrasonic technology to change patient outcomes in Spine, Neuro, and Wound Care. The company is also focused on expanding its presence in emerging markets through partnerships and acquisitions.

Company Snapshot

$38,848.5M

Revenue

254

Employees

1959

Founded

New York, US

Headquarters

SWOT Analysis

Strengths

  • Large customer base
  • Diverse product portfolio

Weaknesses

  • Less revenue generation from international markets

Opportunities

  • Entering emerging countries
  • Supplement organic growth with acquisitions

Threats

  • COVID-19 pandemic
  • Extensive medical device regulation

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
July 2021AcquisitionBioventus Inc.(US) acquired Misonix, Inc.,(US) a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that enhance clinical outcomes. Mixonix offers a SonaStar tumor ablation solution that helps enhance surgery times and remove soft tissue with precision.

Product Offering

  • Misonix, Inc.
    • Tumor Ablation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 38,848.5 Mn in 2019 to USD 74,024.1 Mn in 2021.
Misonix, Inc. — By Business Segment
Series (USD Mn)201920202021
Sales38,848.562,483.774,024.1
R&D Expenditure4,4684,915.95,029.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.